U.S. - Biological Products - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingBiological Product Prices in the United States
U.S. Biological Product Import Price per Ton in June 2022
In June 2022, the biological product price per ton amounted to $2.6M (CIF, US), with an increase of 78% against the previous month. Over the period under review, the import price saw significant growth. As a result, import price attained the peak level and is likely to continue growth in the immediate term.
There were significant differences in the average prices amongst the major supplying countries. In June 2022, the country with the highest price was Ireland ($34.5M per ton), while the price for Poland ($11.6K per ton) was amongst the lowest.
From January 2022 to June 2022, the most notable rate of growth in terms of prices was attained by Canada (+39.0%), while the prices for the other major suppliers experienced more modest paces of growth.
U.S. Biological Product Imports
In July 2022, the amount of biological products imported into the United States shrank slightly to 1.7K tons, declining by -3.7% against June 2022. Overall, imports faced a abrupt decrease. The pace of growth appeared the most rapid in May 2022 when imports increased by 14% month-to-month.
In value terms, biological product imports contracted markedly to $3.7B (IndexBox estimates) in July 2022. Over the period under review, imports continue to indicate a abrupt shrinkage. The growth pace was the most rapid in May 2022 with an increase of 22% month-to-month.
U.S. Biological Product Imports by Country
In June 2022, Canada (649 tons) constituted the largest supplier of biological product to the United States, with a 37% share of total imports. Moreover, biological product imports from Canada exceeded the figures recorded by the second-largest supplier, Germany (198 tons), threefold. China (126 tons) ranked third in terms of total imports with a 7.3% share.
From January 2022 to June 2022, the average monthly rate of growth in terms of volume from Canada totaled -8.2%. The remaining supplying countries recorded the following average monthly rates of imports growth: Germany (-0.3% per month) and China (-47.3% per month).
In value terms, Ireland ($1.7B) constituted the largest supplier of biological product to the United States, comprising 36% of total imports. The second position in the ranking was taken by Germany ($450M), with a 9.8% share of total imports. It was followed by Switzerland, with an 8.6% share.
From January 2022 to June 2022, the average monthly rate of growth in terms of value from Ireland stood at +5.8%. The remaining supplying countries recorded the following average monthly rates of imports growth: Germany (-6.0% per month) and Switzerland (-1.8% per month).
This report provides an in-depth analysis of the biological product market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202120 -
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
- Prodcom 21202160 - Vaccines for veterinary medicine
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
- Prodcom 21202320 - Blood-grouping reagents
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
596
This report provides an in-depth analysis of the biological product market in the U.S..
470
This report provides an in-depth analysis of the antisera market in the U.S..
522
This report provides an in-depth analysis of the vaccine market in the U.S..
360
This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S..
421
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
463
This report provides an in-depth analysis of the global biological product market.
2037
This report provides an in-depth analysis of the global antisera market.
2672
This report provides an in-depth analysis of the global vaccine market.
677
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
529
This report provides an in-depth analysis of the global market for human and animal blood.
146
Haleon invests $54M in its U.S. R&D centre to drive innovation in consumer healthcare, enhancing its product pipeline and maintaining competitive edge.
624
For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by...
146
U.S. experts predict a smaller winter COVID wave, posing challenges for Pfizer amid declining revenues, emphasizing the need to diversify non-COVID products.
273
Explore Moderna's ongoing phase three norovirus vaccine trial targeting urgent prevention needs amid rising outbreaks in the U.S.
239
Moderna has secured $590 million to enhance pandemic influenza vaccine development, focusing on mRNA technology and expanding human trials.
125
Moderna's shares increased by over 10% due to progress in H5N1 vaccine development following a human fatality in the U.S.
111
In the period of 2018 to 2024, the growth of exports for Human And Animal Blood failed to regain momentum. The value of exports declined to $3.5B in 2024.
1387
From February 2023 to December 2023, the exports of Human And Animal Blood saw a significant decline, dropping to $71M in value.
514
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
112
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
